Results 101 to 110 of about 2,195 (166)

The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases. [PDF]

Front Mol Neurosci
Pogoda-Wesołowska A, Sługocka N, Synowiec A, Brodaczewska K, Mejer-Zahorowski M, Ziękiewicz M, Szypowski W, Szymański P, Stępień A.   +8 more
europepmc   +1 more source

Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir. [PDF]

J Virol
Pascoe RD, Kim Y, Rhodes A, Ong J, Tumpach C, Gubser C, Chang JJ, McMahon JH, Lewin SR, Rasmussen TA.   +9 more
europepmc   +1 more source

Improving T-cell engager efficacy in glioblastoma with multi-antigen targeting and novel delivery approaches. [PDF]

Acta Neuropathol
Tiwari A, Pawlowski KD, Balyasnikova IV.
europepmc   +1 more source

Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease. [PDF]

Hum Vaccin Immunother
Glover M, Maher J, Davies DM.
europepmc   +1 more source

Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019. [PDF]

Yonago Acta Med
Nagamizu K, Nishikawa Y, Takata M, Yamaguchi K, Hashimoto Y, Morishita S, Shofiudin MA, Okada K, Kitaura T, Nakamoto M, Yamasaki A, Chikumi H.   +11 more
europepmc   +1 more source

Natural killer cells in the lung: novel insight and future challenge in the airway diseases. [PDF]

ERJ Open Res
Pianigiani T, Paggi I, Cooper GE, Staples KJ, McDonnell M, Bergantini L.   +5 more
europepmc   +1 more source

A New Look at the Role of Radiation-Related Epigenetic Mechanisms in Diagnosis and Anticancer Therapies. [PDF]

Cells
Olichwier AJ, Bruzgo-Grzybko M, Kalita IS, Bielicka N, Chabielska E, Gromotowicz-Poplawska A.   +5 more
europepmc   +1 more source

Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors. [PDF]

Cell Rep Med
Zhu Y, Yu J, Kim YJ, Tian Y, Li Z, Chen Y, Lyu Z, Zhu E, Zhao AS, Ma N, Zhang C, Kramer A, Wilson M, Hon R, Wang YC, Lin S, Shen X, Hahn Z, Zhang Y, Wang A, Li YR, Yang L.   +21 more
europepmc   +1 more source

Peripheral circulating proteomic profiling reveals serum CD80 is positively correlated with the efficacy of neoadjuvant PD-1 blockade combined with chemotherapy for esophagus cancer. [PDF]

BMC Cancer
Wu L, Pan C, Wang W, Gao Y, Cui X, Xie S, Yang B, Yuan J, Chen M, Zhang J, Luo H, Liu T, Zhang G.   +12 more
europepmc   +1 more source